Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
The India-based company Veeda Clinical Research continued...
WuXi PharmaTech Inc., the Shanghai-based CRO, announced...
Perhaps this is the adolescent phase of China biopharma...
Eastern China's Yangtze River Delta is expected to host...
WuXi PharmaTech and Covance have decided not to continue...
China Biologic Products gained control of a...
China Medicine became the first China biopharma to blame...
WuXi PharmaTech released weaker-than-expected financial...
WuXi PharmaTech announced that is has expanded its...
Last week, at ChinaBio®...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China